Phase 2 trial of radiation plus high-dose tamoxifen for glioblastoma multiforme: RTOG protocol BR-0021

Por Robins, H. Ian, Won, M., Seiferheld, Wendy F., Schultz, Christopher J., Choucair, Ali K., Brachman, David G., Demas, William F., Mehta, Minesh P.
Publicado em 2006

Randomized Trial of Radiation Therapy Plus Procarbazine, Lomustine, and Vincristine Chemotherapy for Supratentorial Adult Low-Grade Glioma: Initial Results of RTOG 9802

Por Shaw, Edward G., Wang, Meihua, Coons, Stephen W., Brachman, David G., Buckner, Jan C., Stelzer, Keith J., Barger, Geoffrey R., Brown, Paul D., Gilbert, Mark R., Mehta, Minesh P.
Publicado em 2012

Net Clinical Benefit Analysis of Radiation Therapy Oncology Group 0525: A Phase III Trial Comparing Conventional Adjuvant Temozolomide With Dose-Intensive Temozolomide in Patients...

Por Armstrong, Terri S., Wefel, Jeffrey S., Wang, Meihua, Gilbert, Mark R., Won, Minhee, Bottomley, Andrew, Mendoza, Tito R., Coens, Corneel, Werner-Wasik, Maria, Brachman, David G., Choucair, Ali K., Mehta, Minesh
Publicado em 2013

Effect of the Addition of Chemotherapy to Radiotherapy on Cognitive Function in Patients With Low-Grade Glioma: Secondary Analysis of RTOG 98-02

Por Prabhu, Roshan S., Won, Minhee, Shaw, Edward G., Hu, Chen, Brachman, David G., Buckner, Jan C., Stelzer, Keith J., Barger, Geoffrey R., Brown, Paul D., Gilbert, Mark R., Mehta, Minesh P.
Publicado em 2014

Phase I/II Trial of Temozolomide (TMZ), Motexafin Gadolinium (MGd), and 60 Gy Fractionated Radiation (RT) for Newly Diagnosed Supratentorial Glioblastoma Multiforme (GBM): Final Re...

Por Brachman, David G., Pugh, Stephanie L, Ashby, Lynn S., Thomas, Theresa A., Dunbar, Erin M., Narayan, Samir, Robins, H. Ian, Bovi, Joseph A., Rockhill, Jason K., Won, Minhee, Curran, Walter P.
Publicado no Int J Radiat Oncol Biol Phys (2015)

Phase 2 Study of Temozolomide-based Chemoradiation Therapy for High-risk Low-grade Gliomas: Preliminary Results of Radiation Therapy Oncology Group 0424

Por Fisher, Barbara J., Hu, Chen, Macdonald, David R., Lesser, Glenn J., Coons, Stephen W., Brachman, David G., Ryu, Samuel, Werner-Wasik, Maria, Bahary, Jean-Paul, Liu, Junfeng, Chakravarti, Arnab, Mehta, Minesh
Publicado no Int J Radiat Oncol Biol Phys (2015)

Phase II Trial of Pre-Irradiation and Concurrent Temozolomide in Patients with Newly Diagnosed Anaplastic Oligodendrogliomas and Mixed Anaplastic Oligoastrocytomas: Long Term Resul...

Por Vogelbaum, Michael A., Hu, Chen, Peereboom, David M., Macdonald, David R., Giannini, Caterina, Suh, John H., Jenkins, Robert B., Laack, Nadia N., Brachman, David G., Shrieve, Dennis C., Souhami, Luis, Mehta, Minesh P.
Publicado no J Neurooncol (2015)

THE IMPACT OF CONCURRENT GRANULOCYTE MACROPHAGE-COLONY STIMULATING FACTOR ON QUALITY OF LIFE IN HEAD AND NECK CANCER PATIENTS: RESULTS OF THE RANDOMIZED, PLACEBO-CONTROLED RADIATIO...

Por Hoffman, Karen E., Pugh, Stephanie, James, Jennifer L., Scarantino, Charles, Movsas, Benjamin, Valicenti, Richard K., Fortin, Andre, Pollock, JonDavid, Kim, Harold, Brachman, David G., Berk, Lawrence B., Bruner, Deborah Watkins, Kachnic, Lisa A.
Publicado no Qual Life Res (2014)

Benefit From Procarbazine, Lomustine, and Vincristine in Oligodendroglial Tumors Is Associated With Mutation of IDH

Por Cairncross, J. Gregory, Wang, Meihua, Jenkins, Robert B., Shaw, Edward G., Giannini, Caterina, Brachman, David G., Buckner, Jan C., Fink, Karen L., Souhami, Luis, Laperriere, Normand J., Huse, Jason T., Mehta, Minesh P., Curran, Walter J.
Publicado em 2014

NC-05 ASSOCIATION OF NEUROCOGNITIVE AND PATIENT REPORTED OUTCOMES WITH THE PRESENCE OF RESIDUAL DISEASE FOLLOWING SURGICAL RESECTION IN GLIOBLASTOMA (GBM)

Por Hall, William A., Pugh, Stephanie L., Wefel, Jeffrey S., Armstrong, Terri S., Gilbert, Mark R., Brachman, David G., Werner-Wasik, Maria, Wendland, Merideth, Brown, Paul D., Chao, Samuel T., Roof, Kevin, Robins, H. Ian, Curran, Walter J., Mehta, Minesh
Publicado em 2014

RTOG 0211: A Phase I/II Study of Radiation Therapy with Concurrent Gefitinib for Newly Diagnosed Glioblastoma Patients

Por Chakravarti, Arnab, Wang, Meihua, Robins, H. Ian, Lautenschlaeger, Tim, Curran, Walter J., Brachman, David G., Schultz, Christopher J., Choucair, Ali, Dolled-Filhart, Marisa, Christiansen, Jason, Gustavson, Mark, Molinaro, Annette, Mischel, Paul, Dicker, Adam P., Bredel, Markus, Mehta, Minesh
Publicado em 2012

RTRB-03 SHORT DELAY IN INITIATION OF RADIOTHERAPY WITH CONCURRENT CHEMOTHERAPY FOR GLIOBLASTOMA: A SECONDARY ANALYSIS OF NRG ONCOLOGY/RTOG 0525 AND 0825

Por Blumenthal, Deborah T., Won, Minhee, Corn, Benjamin W., Gilbert, Mark R., Brown, Paul, Bokstein, Felix, Brachman, David G., Werner-Wasik, Maria, Hunter, Grant K., Valeinis, Egils, Kuehn, Eric F., Hopkins, Kirsten, Souhami, Luis, Robins, H. Ian, Zhang, Peixin, Mehta, Minesh P.
Publicado no Neuro Oncol (2015)

A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma

Por Gilbert, Mark R., Dignam, James J., Armstrong, Terri S., Wefel, Jeffrey S., Blumenthal, Deborah T., Vogelbaum, Michael A., Colman, Howard, Chakravarti, Arnab, Pugh, Stephanie, Won, Minhee, Jeraj, Robert, Brown, Paul D., Jaeckle, Kurt A., Schiff, David, Stieber, Volker W., Brachman, David G., Werner-Wasik, Maria, Tremont-Lukats, Ivo W., Sulman, Erik P., Aldape, Kenneth D., Curran, Walter J., Mehta, Minesh P.
Publicado em 2014

EPID-25 GERMLINE POLYMORPHISMS IN MGMT INCREASE ABILITY TO MODEL TEMOZOLOMIDE (TMZ)-RELATED MYELOTOXICITY RISK IN PATIENTS WITH GLIOBLASTOMA (GBM) TREATED ON NRG ONCOLOGY/RTOG 0825

Por Scheurer, Michael E., Zhou, Renke, Gilbert, Mark R., Bondy, Melissa L., Sulman, Erik P., Yuan, Ying, Liu, Yanhong, Vera-Bolanos, Elizabeth, Wendland, Merideth M., Brachman, David G., Stieber, Volker W., Komaki, Ritsuko R., Flickinger, John C., Kenyon, Lawrence C., Robins, H. Ian, Hunter, Grant K., Crocker, Ian R., Chao, Samuel T., Stella, Philip J., Pugh, Stephanie L., Armstrong, Terri
Publicado no Neuro Oncol (2015)